Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.

The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries

Open access
Gleeson, Deborah, Lexchin, Joel, Lopert, Ruth, Kilic, Burcu · 2018 · Global Social Policy

Abstract

The final text of the Trans Pacific Partnership Agreement (TPP), agreed between the 12 negotiating countries in 2016, included a suite of intellectual property provisions intended to expand and extend pharmaceutical company exclusivities on medicines. It drew wide criticism for including such provisions in an agreement that involved developing countries (Vietnam, Peru, Malaysia, Mexico, Chile and Brunei Darussalam) because of the effect on delaying the introduction of low-cost generics. While developing nations negotiated transition periods for implementing some obligations, all parties would have eventually been expected to meet the same standards had the TPP come into force. While the TPP has stalled following US withdrawal, there are moves by some of the remaining countries to reinvigorate the agreement without the United States. The proponents may seek to retain as much as possible of the original text in the hope that the United States will re-join the accord in future. This article presents a comparative analysis of the impact the final 2016 TPP intellectual property chapter could be expected to have (if implemented in its current form) on the intellectual property laws and regulatory regimes for medicines in the TPP countries. Drawing on the published literature, it traces the likely impact on access to medicines. It focuses particularly on the differential impact on regulatory frameworks for developed and developing nations (in terms of whether or not legislative action would have been required to implement the agreement). The article also explores the political and economic dynamics that contributed to these differential outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1468018117734153

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Research works printed but not linked: 7

  1. Kelsey J (2013) Press release: Heavy-handed tactics in TPPA talks aim to isolate dissenters. Available at: https://itsourfuture.org.nz/heavy-handed-tactics-in-tppa-talks-aim-to-isolate-dissenters/ (accessed 28 May 2017).
  2. Palmedo M, 2013, Currents International Trade Law Journal, 21, 38
  3. Park W, 2007, Frontiers of Economics and Globalisation. Amsterdam: Elsevier, 289
  4. Pharmaceutical Research and Manufacturers of America (2013) PhRMA Urges Trans-Pacific Partnership negotiators to adopt a strong intellectual property framework. Available at: http://www.phrma.org/press-release/phrma-urges-trans-pacific-partnership-negotiators-to-adopt-a-strong-intellectual-property-framework (accessed 21 May 2017).
  5. Scassa T, 2001, Health Law Journal, 9, 23
  6. Trans Pacific Partnership (2011) Intellectual property rights chapter draft, 10 February. Available at: http://keionline.org/sites/default/files/tpp-10feb2011-us-text-ipr-chapter.pdf (accessed 17 August 2013).
  7. Trans Pacific Partnership (2016) Trans Pacific Partnership Agreement chapter 18: Intellectual property. Available at: https://www.mfat.govt.nz/assets/_securedfiles/trans-pacific-partnership/text/18.intellectual-property-chapter.pdf (accessed 9 June 2017).

Cited by

See all 41

Metadata

Authors
Gleeson, D., Lexchin, J., Lopert, R., & Kilic, B.
Affiliations
  • La Trobe University (AU)
  • York University (CA)
  • George Washington University (US)
  • Public Citizen (US)
Corresponding author
Gleeson, Deborah
Venue
Global Social Policy
Published
2017-10-13
Volume
18
Issue
1
Pages
7-27
ISSN
  • 1468-0181 (ISSN-L)
  • 1741-2803
OpenAlex
W2765265353
Cited by
41
References
37
Citations by year
2026: 2 · 2025: 3 · 2024: 7 · 2023: 4 · 2021: 5 · 2020: 10 · 2019: 6 · 2018: 4
FWCI
9.84
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Global Social Policy (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by-nc)
  • La Trobe University
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Social Sciences › Law › Intellectual Property Law
  • Social Sciences › Business, Management and Accounting › Management of Technology and Innovation › Intellectual Property and Patents
Keywords
Trans-Pacific Partnership, intellectual property, pharmaceutical patents, access to medicines, generic drugs, developing countries, developed countries, trade agreements, drug exclusivity, US withdrawal from TPP

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries. https://app.cochat.ai/papers/10.1177/1468018117734153
The paper
Gleeson, D., Lexchin, J., Lopert, R., & Kilic, B. (2018). The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries. Global Social Policy. https://doi.org/10.1177/1468018117734153

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.